| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM198512123132402 |
| P698 | PubMed publication ID | 2999592 |
| P50 | author | Jörg Schüpbach | Q40184703 |
| P2093 | author name string | Müller F | |
| Vogt M | |||
| Groopman JE | |||
| Resnick L | |||
| Ho DD | |||
| Markham PD | |||
| Tourtellotte WW | |||
| Shapshak P | |||
| diMarzo-Veronese F | |||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV/AIDS | Q12199 |
| blood–brain barrier | Q221694 | ||
| P304 | page(s) | 1498-1504 | |
| P577 | publication date | 1985-12-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex | |
| P478 | volume | 313 |
| Q37779726 | A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. |
| Q68072122 | A new complement fixation test for the diagnosis of neurocysticercosis in cerebrospinal fluid |
| Q71342837 | A novel approach to the determination and characterization of HIV dementia |
| Q39594463 | AIDS and the geriatrician |
| Q70246893 | AIDS dementia |
| Q38680597 | AIDS-dementia-complex: pathology, pathogenesis and future directions |
| Q44767863 | AIDS-related optic neuropathy: a histological, virological and ultrastructural study |
| Q70179966 | Acquired immune deficiency syndrome presenting as progressive infantile encephalopathy |
| Q39755536 | Acquired immunodeficiency syndrome of childhood |
| Q34195534 | Acquired immunodeficiency syndrome presenting as schizophrenia |
| Q33933248 | Acute infection with human immunodeficiency virus presenting with neurogenic urinary retention |
| Q34558599 | Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex |
| Q48300707 | Advanced laboratory techniques for diagnosing Toxoplasma gondii encephalitis in AIDS patients: significance of intrathecal production and comparison with PCR and ECL-western blotting |
| Q44076429 | Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV. |
| Q33631223 | Anti-HIV antibodies in the CSF of AIDS patients: a serological and immunoblotting study |
| Q45846899 | Antibody specificity for human immunodeficiency virus type 1 in serum and cerebrospinal fluid from patients with AIDS and AIDS-related complex |
| Q33491466 | Anticardiolipin antibodies in HIV infection: association with cerebral perfusion defects as detected by 99mTc-HMPAO SPECT. |
| Q44036228 | Antiretroviral therapy and immunologic reconstitution in AIDS. |
| Q50759629 | Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders. |
| Q47919319 | Autoimmune markers in HIV-associated dementia |
| Q34177897 | Brain imaging in acquired immunodeficiency syndrome dementia complex |
| Q45831679 | Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases |
| Q36802755 | CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1 |
| Q35654754 | Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease |
| Q58480262 | Cerebrospinal fluid antiganglioside antibodies in patients with AIDS |
| Q48124149 | Chronic HIV encephalitis--II. Clinical aspects |
| Q34729109 | Chronic viral diseases |
| Q44035134 | Clinical Manifestations of HIV Infection in Children |
| Q36335282 | Clinical manifestations, management and therapy of HIV infection in children |
| Q24648466 | Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes |
| Q38551796 | Compartmentalized intrathecal immunoglobulin synthesis during HIV infection - a model of chronic CNS inflammation? |
| Q36635851 | Cross-reactivity of anti-human immunodeficiency virus type 1 gp41 antibodies with human astrocytes and astrocytoma cell lines. |
| Q68236788 | Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein |
| Q36232123 | Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease |
| Q44596694 | Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients |
| Q39507330 | Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature |
| Q40385037 | Dementia and ataxia in a patient with AIDS. |
| Q44044033 | Developmental abnormalities in children with acquired immunodeficiency syndrome (AIDS): a follow-up study |
| Q33390496 | Early HIV-related neuropsychological impairment: relationship to stage of viral infection |
| Q35831494 | Early viral replication in the brain of SIV-infected rhesus monkeys |
| Q33929164 | Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity |
| Q43805861 | Estimation of the lipophilicity of anti-HIV nucleoside analogues by determination of the partition coefficient and retention time on a Lichrospher 60 RP-8 HPLC column |
| Q37184136 | Evaluation of a human immunodeficiency virus test algorithm utilizing a recombinant protein enzyme immunoassay |
| Q70180152 | Evidence for different immune responses to HIV in CSF and serum? |
| Q45840125 | Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection |
| Q44128855 | Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection |
| Q69596586 | HIV-1 core proteins expressed from recombinant vaccinia viruses |
| Q45417303 | Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection. |
| Q38266133 | Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis |
| Q45832366 | Human immunodeficiency virus and papovavirus infections in acquired immunodeficiency syndrome: an ultrastructural study of three cases |
| Q33559155 | Human immunodeficiency virus infection and diffuse polyneuropathy. Implications for rehabilitation medicine |
| Q72470498 | Human spumaretrovirus antibody reactivity in multiple sclerosis |
| Q33631484 | Immunocytochemical demonstration of human immunodeficiency virus infected cells in the cerebrospinal fluid |
| Q68043632 | Immunoglobulin G subclass preference of intrathecally produced HIV-specific oligoclonal antibodies |
| Q36375893 | Immunotherapeutic relief from persistent infections and amyloid disorders. |
| Q35188470 | Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5. |
| Q36832031 | Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope |
| Q51025141 | Influence of depressed mood on neuropsychologic performance in HIV‐seropositive drug users |
| Q34589369 | Insights into the role of immune activation in HIV neuropathogenesis |
| Q34628871 | Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees |
| Q67691879 | Intrathecal IgG synthesis and specificity of oligoclonal IgG in patients infected with HIV-1 do not correlate with CNS disease |
| Q48150591 | Intrathecal production of HIV antibodies in suspected AIDS encephalopathy |
| Q43172802 | Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. |
| Q45833635 | Intrathecal synthesis of specific IgG in syphilitic patients with human immunodeficiency virus 1 infection |
| Q45845113 | Intrathecal synthesis of virus-specific oligoclonal antibodies in patients with enterovirus infection of the central nervous system |
| Q73850558 | Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system |
| Q45848161 | Isolation of the human T-cell leukemia/lymphotropic virus type III from aqueous humor in two patients with perivasculitis of the retinal vessels |
| Q36750975 | Laboratory evaluations in HIV-1-associated cognitive/motor complex. |
| Q68748073 | Legal control measures for AIDS: reporting requirements, surveillance, quarantine, and regulation of public meeting places |
| Q92192788 | Mass Spectrometry Imaging Demonstrates the Regional Brain Distribution Patterns of Three First-Line Antiretroviral Drugs |
| Q34203154 | Mechanisms of infectivity and replication of HIV-1 and implications for therapy |
| Q34309557 | Microglia in HIV-associated neurological diseases |
| Q40116997 | Mutational analysis of the human immunodeficiency virus vpr open reading frame. |
| Q48132055 | Myelopathy in AIDS. A clinical and electrophysiological study of 23 Danish patients |
| Q45847347 | Neurodevelopmental delay and focal seizures as presenting symptoms of human immunodeficiency virus I infection |
| Q38960541 | Neuroepidemiology of HIV infection |
| Q34306701 | Neuroimmune and neurovirological aspects of human immunodeficiency virus infection |
| Q45835415 | Neurologic complications of human immunodeficiency virus infection. What diagnostic features to look for. |
| Q39663214 | Neurological complications in AIDS. |
| Q39183384 | Neurological complications of human immunodeficiency virus infection |
| Q61671928 | Neurological features in AIDS patients: Studies on cerebrospinal fluid |
| Q43174350 | Neurological manifestations of human immunodeficiency virus infection |
| Q36989584 | Neurology of AIDS virus infection: a clinical classification |
| Q59545721 | Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland |
| Q45780098 | Neuropsychologic functioning of human immunodeficiency virus-infected children with hemophilia |
| Q52113176 | Neuropsychological performance in HIV-1 immunocompromised patients: a preliminary report. |
| Q45100211 | Neuroradiological manifestations of acquired immunodeficiency syndrome |
| Q45839903 | Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders |
| Q40699057 | Ophthalmoplegia associated with AIDS. |
| Q39692591 | Pathogenesis of human immunodeficiency virus infection and prospects for control |
| Q38164170 | Pathogenesis of lentivirus infections |
| Q40874333 | Pathogenesis of virus-induced demyelination. |
| Q40485871 | Pediatric HIV Infection: A Neuropsychological and Educational Challenge |
| Q70755536 | Predictive value of neurological abnormalities in HIV 1 patients in the early stages of the infection |
| Q39583105 | Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques. |
| Q41529059 | Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis |
| Q41343118 | Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine |
| Q37409831 | Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes |
| Q38172146 | Strategies for antiviral therapy in AIDS. |
| Q39581553 | Strengths and weaknesses in methods for identifying the causative agent(s) of acquired immunodeficiency syndrome (AIDS). |
| Q41962992 | Subclinical neurological and neuropsychological effect of infection with HIV. |
| Q44689321 | Sudden sensorineural hearing loss as a presentation of HIV infection |
| Q42587163 | T cell subsets in AIDS: relationships between peripheral blood and cerebrospinal fluid |
| Q40431620 | The Pathogenesis of HIV Infections of the Brain |
| Q38366893 | The immunopathogenesis of HIV infection |
| Q35836258 | The neuropathology of AIDS. UCLA experience and review |
| Q35614482 | The neuropathology of pediatric acquired immunodeficiency syndrome |
| Q30411844 | The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders |
| Q40664855 | The virology of demyelinating diseases |
Search more.